These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

109 related articles for article (PubMed ID: 1661686)

  • 1. Binding of truncated peptides to the MHC molecule IA (d).
    Dornmair K; Clark BR; McConnell HM
    FEBS Lett; 1991 Dec; 294(3):244-6. PubMed ID: 1661686
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Probing the accessibility of peptide in an MHC class II protein--foreign peptide complex.
    Gariépy J; Watts TH
    Int Immunol; 1991 Mar; 3(3):279-84. PubMed ID: 2049342
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Energy transfer between two peptides bound to one MHC class II molecule.
    Tampé R; Clark BR; McConnell HM
    Science; 1991 Oct; 254(5028):87-9. PubMed ID: 1656526
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Recognition of core and flanking amino acids of MHC class II-bound peptides by the T cell receptor.
    Sant'Angelo DB; Robinson E; Janeway CA; Denzin LK
    Eur J Immunol; 2002 Sep; 32(9):2510-20. PubMed ID: 12207335
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Structural analysis of peptides capable of binding to more than one Ia antigen.
    Sette A; Buus S; Colon S; Miles C; Grey HM
    J Immunol; 1989 Jan; 142(1):35-40. PubMed ID: 2535860
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Analysis of peptide binding patterns in different major histocompatibility complex/T cell receptor complexes using pigeon cytochrome c-specific T cell hybridomas. Evidence that a single peptide binds major histocompatibility complex in different conformations.
    Bhayani H; Paterson Y
    J Exp Med; 1989 Nov; 170(5):1609-25. PubMed ID: 2553848
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Inhibition of class II MHC-peptide complex formation by protease inhibitors.
    Liang MN; Witt SN; McConnell HM
    J Immunol Methods; 1994 Jul; 173(1):127-31. PubMed ID: 8034980
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Emerging principles for the recognition of peptide antigens by MHC class I molecules.
    Matsumura M; Fremont DH; Peterson PA; Wilson IA
    Science; 1992 Aug; 257(5072):927-34. PubMed ID: 1323878
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Functional mapping of MHC class II polymorphic residues. The alpha-chain controls the specificity for binding an Ad-versus an A k-restricted peptide and the beta-chain region 65-67 controls T cell recognition but not peptide binding.
    Lee JM; McKean DJ; Watts TH
    J Immunol; 1991 May; 146(9):2952-9. PubMed ID: 1849939
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Expression of endogenous peptide-major histocompatibility complex class II complexes derived from invariant chain-antigen fusion proteins.
    Sanderson S; Frauwirth K; Shastri N
    Proc Natl Acad Sci U S A; 1995 Aug; 92(16):7217-21. PubMed ID: 7638170
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Invariant chain can bind MHC class II at a site other than the peptide binding groove.
    Wilson NA; Wolf P; Ploegh H; Ignatowicz L; Kappler J; Marrack P
    J Immunol; 1998 Nov; 161(9):4777-84. PubMed ID: 9794409
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Ovalbumin(323-339) peptide binds to the major histocompatibility complex class II I-A(d) protein using two functionally distinct registers.
    McFarland BJ; Sant AJ; Lybrand TP; Beeson C
    Biochemistry; 1999 Dec; 38(50):16663-70. PubMed ID: 10600129
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Formation and dissociation of short-lived class II MHC-peptide complexes.
    Witt SN; McConnell HM
    Biochemistry; 1994 Feb; 33(7):1861-8. PubMed ID: 8110789
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Studies on the nature of physiologically processed antigen and on the conformation of peptides required for interaction with MHC.
    Grey HM; Demotz S; Buus S; Sette A
    Cold Spring Harb Symp Quant Biol; 1989; 54 Pt 1():393-9. PubMed ID: 2639761
    [No Abstract]   [Full Text] [Related]  

  • 15. Refolding and reassembly of separate alpha and beta chains of class II molecules of the major histocompatibility complex leads to increased peptide-binding capacity.
    Dornmair K; McConnell HM
    Proc Natl Acad Sci U S A; 1990 Jun; 87(11):4134-8. PubMed ID: 2349223
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Kinetics of peptide binding to the class II MHC protein I-Ek.
    Kasson PM; Rabinowitz JD; Schmitt L; Davis MM; McConnell HM
    Biochemistry; 2000 Feb; 39(5):1048-58. PubMed ID: 10653650
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Peptide-induced conformational changes in class I heavy chains alter major histocompatibility complex recognition.
    Bluestone JA; Jameson S; Miller S; Dick R
    J Exp Med; 1992 Dec; 176(6):1757-61. PubMed ID: 1460430
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Predominant naturally processed peptides bound to HLA-DR1 are derived from MHC-related molecules and are heterogeneous in size.
    Chicz RM; Urban RG; Lane WS; Gorga JC; Stern LJ; Vignali DA; Strominger JL
    Nature; 1992 Aug; 358(6389):764-8. PubMed ID: 1380674
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Comparison of structural requirements for interaction of the same peptide with I-Ek and I-Ed molecules in the activation of MHC class II-restricted T cells.
    Leighton J; Sette A; Sidney J; Appella E; Ehrhardt C; Fuchs S; Adorini L
    J Immunol; 1991 Jul; 147(1):198-204. PubMed ID: 1711074
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Antigen presentation. One size fits all.
    Rothbard JB
    Curr Biol; 1994 Jul; 4(7):653-5. PubMed ID: 7953548
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.